The human type II collagen (Col II), specifcally expressed in chondrocytes, is a crucial component
of the adult hyaline cartilage. We examine the potential of artifcial induction of Col II in human
peripheral blood mononuclear cells (PBMNCs) as a novel Col II provider. Human PBMNCs were purifed
and were treated with high doses of macrophage-colony stimulating factor (M-CSF), granulocyte
macrophage-colony stimulating factor (GM-CSF), or granulocyte-colony stimulating factor (G-CSF)
and examined the Col II expression at indicated days. Quantitative Col II expression was validated by
real-time reverse transcriptase-polymerase chain reaction (RT-PCR), immunocytochemistry, and fow
cytometry. We demonstrate that monocytes in PBMNCs can be artifcially induced to express both
Col II proteins and M2 macrophage markers by the high concentration of colony-stimulating factors,
especially M-CSF and GM-CSF. The Col II proteins were detected on the cell membrane and in the
cytoplasm by fow cytometry and immunocytostaining. Combination with IL-4 provided a synergistic
efect with M-CSF/GM-CSF to trigger Col II expression in M2 macrophages. These CD206 and Col II
double-expressing cells, named modifed macrophages, share M2 macrophages’ anti-infammatory
potency. We demonstrated that the modifed macrophages could signifcantly attenuate the
infammatory progress of Complete Freund’s adjuvant (CFA)-induced arthritis and collagen-induced
arthritis in rodents. Here, we provide the frst evidence that a modifed macrophage population could
ectopically express Col II and control the progress of arthritis in animals.